AtriCure Q4 Adj. EPS $0.06 Beats $(0.10) Estimate, Sales $140.500M Beat $139.777M Estimate
AtriCure, Inc. +1.52% Pre
AtriCure, Inc. ATRC | 28.66 28.66 | +1.52% 0.00% Pre |
AtriCure (NASDAQ:
ATRC) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.10) by 163.16 percent. This is a 175 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $140.500 million which beat the analyst consensus estimate of $139.777 million by 0.52 percent. This is a 13.05 percent increase over sales of $124.277 million the same period last year.
